IN Capital strives to become the leading healthcare investment firm in China
Xiangru Cheng

Mr. Cheng has a professional background in biomedicine. He graduated from the University of Melbourne with a master's degree in biomedicine,aimed at biochemistry, molecular biology and structural biology. He studied the structure and function of viral proteins at the Bio21 Institute of molecular science and biotechnology in Australia.

Mr. Cheng graduated from Henan University majoring in biopharmaceutics and spent one year studying and researching biochemistry and natural pharmaceutical chemistry in the Institute of medicine, Chinese Academy of Medical Sciences.

Copyright © In Capital 2019